Editas Medicine, Inc.
NASDAQEDIT cost to borrow surges 111% in one week to 0.44%, signaling tighter short supply amid persistent 10.2% short interest.
Snapshot as of 30 Jun 2026
No long-form analysis yet for EDIT. Pulse alerts and the live data picture are available on ORTEX.
Open EDIT on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EDIT — free to start on ORTEX.
Sign up for free →Open EDIT on ORTEX